Synfini, Inc., is a pioneer in agile chemistry. Its advanced, automated molecular discovery platform is transforming drug discovery through integrated neuro-symbolic AI, discovery-focused robotic automation, and world-class chemistry data.
Note from the editor
Synfini, Inc., is a pioneer in agile chemistry. Its advanced, automated molecular discovery platform is transforming drug discovery through integrated neuro-symbolic AI, discovery-focused robotic automation, and world-class chemistry data.
Peter Madrid is a Co-Founder and Head of Scientific Discovery at Synfini Inc., a biotech firm integrating lab and virtual chemistry to speed up drug discovery.